GLAXOSMITHKLINE
SHARE PRICE
1,824.50
CHANGE
3.50 ( 0.19%)
TICKER
GSK.L
Share Chart
Latest Articles for GSK.L
GSK hails positive opinion by EU's CHMP on depemokimab and Nucala
(Alliance News) - GSK PLC on Friday said the Committee for Medicinal Products for Human Use of the European Medicines Agency recommended the approval of depemokimab in two indications....
GSK's Arexvy on track for wider age range approval in Europe
(Alliance News) - GSK PLC on Friday said European regulators have recommended broadening the indication for its Arexvy vaccine to all adults aged 18 and older. ...
LONDON BRIEFING: FTSE 100 to rise, UK GDP down, trade deficit spikes
(Alliance News) - Stocks were called to open higher in London on Friday, as the Office for National Statistics reported that the UK economy unexpectedly shrank in October....
IN BRIEF: GSK says US FDA backs supplemental gepotidacin application
GSK PLC - London-based pharmaceuticals firm - US Food & Drug Administration approves a supplemental new drug application for gepotidacin as an oral option for adult and paediatric patients from...